Abstract
Inherited defects in myocardial long-chain fatty acid metabolism are increasingly recognized as a cause of cardiomyopathy and sudden death in children. To evaluate whether the phenotypic expression of these genetic diseases could be delineated using positron emission tomography (PET), 11 patients with inherited defects in fatty acid metabolism were evaluated and results were compared with those of 6 nonaffected siblings. Myocardial perfusion, myocardial oxygen consumption (MVO2), and long-chain fatty acid metabolism were determined noninvasively with PET using quantitative mathematical models. There were no differences in haemodynamics, perfusion, MVO2 or plasma substrate levels between groups. Patients with defects in enzymes of fatty acid β-oxidation (acyl-CoA dehydrogenase and 3-hydroxyacyl-CoA dehydrogenase deficiencies) n = 5 had diminished myocardial palmitate oxidation compared with healthy siblings (3.2 ± 3.0 vs 13.0 ± 5.6 nmol/g per min, p < 0.03) and a decrease in the percentage of MVO2 accounted for by palmitate (2% ± 3% vs 9% ± 5%), p > 0.04). In these patients, extracted palmitate was shunted into a slow-turnover compartment (predominantly reflecting esterification to triglycerides) with expansion of palmitate in that pool (185 ± 246 compared with 27 ± 67 nmol/g in healthy siblings, p < 0.02). In contrast, myocardium of patients with carnitine deficiency (n = 6 (all on oral carnitine therapy) had normal palmitate extraction but expansion of the interstitial/cytosolic fatty acid pool (617 ± 399 vs 261 ± 73 nmol/g in healthy siblings, p < 0.04), suggesting different mechanisms for handling upstream fatty acyl intermediates. Thus, PET can be used to noninvasively assess abnormal myocardial handling of fatty acids in patients with inherited defects of metabolism. This approach should be useful in the assessment of altered myocardial fatty acid metabolism associated with cardiomyopathy as well as for evaluating the efficacy of therapeutic interventions in affected patients.
Similar content being viewed by others
REFERENCES
Amendt BA, Moon A, Teel L, Rhead WJ (1988) Long-chain acyl-coenzyme A dehydrogenase deficiency: biochemical studies in fibroblasts from three patients. Pediatr Res 23: 603-605.
Bergmann SR, Herrero P, Markham J, Weinheimer CJ, Walsh MN (1989) Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 14: 639-652.
Bergmann SR, Weinheimer CJ, Markham J, Herrero P (1996) Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med 37: 1723-1730.
Brown MA, Marshall DR, Sobel BE, Bergmann SR (1986) Delineation of myocardial oxygen utilization with carbon-11 labeled acetate. Circulation 76: 687-696.
Brown MA, Mycars DW, Bergmann SR (1988) Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography. J Am Coll Cardiol 12: 1054-1063.
Brown MA, Myears DW, Bergmann SR (1989) Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 30: 187-193.
Buck A, Wolpers HG, Hutchins GD, et al (1991) Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med 32: 1950-1957.
Camici P, Marraccini P, Marzilli M et al (1989a) Coronary hemodynamics and myocardial metabolism during and after pacing stress in normal humans. Am J Physiol 257: E309-317.
Camici P, Ferrannini E, Opie LH (1989b) Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 32: 217-238.
Corr PB, Yamada KA (1995) Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis. Herz 20: 156-168.
Duran M, Kofkamp M, Rhead WJ, Saudubray JM, Wadman SK (1986) Sudden child death and “healthy” affected family members with medium-chain acyl-coenzyme A dehydrogenase deficiency. Pediatrics 78: 1052-1057.
Fox, KAA, Abendschein DR, Ambos HD, Sobel BE, Bergmann SR (1985) Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically. Circ Res 57: 232-243.
Frerman FE, Goodman SI (1985) Fluorometric assay of acyl-CoA dehydrogenases in normal and mutant human fibroblasts. Biochem Med 33: 38-44.
Gropler RJ, Shelton ME, Herrero P, Walsh JF, Bergmann SR (1993) Measurement of myocardial oxygen consumption using positron emission tomography and C-11 acetate: Direct validation in human subjects. Circulation 88: 1-172 (Abstract).
Hale DE, Bennett MJ (1992) Fatty acid oxidation disorders: a new class of metabolic diseases. J Pediatr 121: 1-11.
Hale DE, Batshaw ML, Coates PM, et al (1985) Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatr Res 19: 666-671.
Herrero P, Markham J, Bergmann SR (1989) Quantitation of myocardial blood flow with H2 15O and positron emission tomography: assessment and error analysis of a mathematical approach. J Comput Assist Tomogr 13: 862-873.
Herrero P, Hartman JJ, Senneff MJ, Bergmann SR (1994) Effects of time discrepancies between input and myocardial time-activity curves on estimates of regional myocardial perfusion with PET. J Nucl Med 35: 558-566.
Herrero P, Gropler RJ, Shelton ME, Bergmann SR (1996) Use of compartmental models of carbon-11 acetate to measure myocardial oxygen consumption: validation in human subjects. J Nucl Med 37: 222P (abstract).
Kelly CL, Rhead WJ, Kutschke WK, et al (1997) Functional correction of short-chain acyl-CoA dehydrogenase deficiency in transgenic mice: implications for gene therapy of human mitochondrial enzyme deficiencies. Hum Mol Genet 6: 1451-1455.
Kelly DP, Strauss AW (1994) Inherited cardiomyopathies. N Engl J Med 330: 913-919.
Kelly DP, Mendelsohn NJ, Sobel BE, Bergmann SR (1993) Detection and assessment by positron emission tomography of a genetically determined defect in myocardial fatty acid utilization (long-chain acyl-CoA dehydrogenase deficiency). Am J Cardiol 71: 738-744.
Naylor FW, Mosovich LL, Guthrie R, Evans JE, Tieckelmann H (1980) Intermittent nonketotic dicarboxylic aciduria in two siblings with hypoglycemia: an apparent defect in β-oxidation of fatty acids. J Inherit Metab Dis 3: 19-24.
Rhead WJ, Mendt BA, Fritchman KS, Felts SJ (1983) Dicarboxylic aciduria: deficient [1-14C]octanoate oxidation and medium-chain acyl-CoA dehydrogenase in fibroblasts. Science 221: 73-75.
Roe CR, Coates PM (1989) Acyl-CoA dehydrogenase deficiencies. In Scriver C, Valle D, eds. The Metabolic Basis of Inherited Diseases, 6th edn. New York: McGraw Hill, 889-914.
Rosamond TL, Abendschein DR, Sobel BE, Bergmann SR, Fox KAA (1987) Metabolic fate of radiolabeled palmitate in ischemic canine myocardium: implications for positron emission tomography. J Nucl Med 28: 1322-1329.
Saudubray JM, Martin D, De Lonlay P, et al (1999) Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 22: 488-502.
Schwenk WF, Hale DE, Haymond MW (1988) Decreased fasting free fatty acids with L-carnitine in children with carnitine deficiency. Pediatr Res 23: 491-494.
Wanders RJA, Vreken P, Den Boer MEJ, Wijburg FA, Van Gennip AH, Ijlst L (1999) Disorders of mitochondrial fatty acyl-CoA β-oxidation. J Inherit Metab Dis 22: 442-487.
Welch MJ, Dence CS, Marshall DR, Kilbourn MR (1983) Remote system for production of carbon-11 labeled palmitic acid. J Label Compounds Radiopharm 20: 1087-1095.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bergmann, S.R., Herrero, P., Sciacca, R. et al. Characterization of altered myocardial fatty acid metabolism in patients with inherited cardiomyopathy. J Inherit Metab Dis 24, 657–674 (2001). https://doi.org/10.1023/A:1012711009687
Issue Date:
DOI: https://doi.org/10.1023/A:1012711009687